Can a common ectopic pregnancy drug work in women with kidney or liver issues?

NCT ID NCT07186127

Recruiting now Knowledge-focused Sponsor: Bagcilar Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study reviews medical records of 230 women treated with methotrexate for ectopic pregnancy, focusing on those with conditions that usually make this drug risky, like kidney or liver problems. Researchers will check how well the treatment worked by measuring pregnancy hormone levels and whether surgery was needed. The goal is to gather real-world data to help doctors make better decisions for similar patients in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Methotrexate
What this could lead to: If successful, this study could help doctors understand when it is safe to use methotrexate for ectopic pregnancy in women with kidney or liver issues.
What could go wrong: This is a retrospective study, meaning it looks back at old records, not a controlled trial. Results may not apply to all patients, and the study cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ECTOPIC PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ectopic pregnancy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ECTOPIC PREGNANCY

Contacts and locations

Locations

University of Health Sciences, Training and Research Hospital
RECRUITING

Istanbul, Türkiye, 34200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.